226
Views
5
CrossRef citations to date
0
Altmetric
Research Articles

Preparation and characterization of metformin hydrochloride controlled-release tablet using fatty acid coated granules

ORCID Icon, , , , , , & show all
Pages 852-860 | Received 07 Dec 2019, Accepted 25 Apr 2020, Published online: 12 May 2020

References

  • Barner JC. Adherence to oral antidiabetic agents with pioglitazone and metformin: comparison of fixed-dose combination therapy with monotherapy and loose-dose combination therapy. Clin Ther. 2011;33:1281–1288.
  • Vistisen D, Lee CM, Colagiuri S, et al. A globally applicable screening model for detecting individuals with undiagnosed diabetes. Diabetes Res Clin Pract. 2012;95:432–438.
  • Ogurtsova K, da Rocha Fernandes J, Huang Y, et al. IDF diabetes atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50.
  • Veltkamp SA, van Dijk J, Collins C, et al. Combination treatment with ipragliflozin and metformin: a randomized, double-blind, placebo-controlled study in patients with type 2 diabetes mellitus. Clin Ther. 2012;34:1761–1771.
  • Kabir AKL, Jeseem T, Jahangir R, et al. Formulation development and in vitro evaluation of metformin hydrochloride matrix tablets based on hydroxypropyl methyl cellulose. S J Pharm Sci. 2008;1:51–56.
  • Mandal U, Gowda V, Ghosh A, et al. Formulation and optimization of sustained release matrix tablet of metformin HCl 500 mg using response surface methodology. Yakugaku Zasshi. 2007;127:1281–1290.
  • Qin C, He W, Zhu C, et al. Controlled release of metformin hydrochloride and repaglinide from sandwiched osmotic pump tablet. Int J Pharm X. 2014;466:276–285.
  • Gandhi R, Kaul CL, Panchagnula R. Extrusion and spheronization in the development of oral controlled-release dosage forms. Pharm Sci Tech Today. 1999;2:160–170.
  • Alabi CO, Singh I, Odeku OA. Evaluation of natural and pregelatinized forms of three tropical starches as excipients in tramadol tablet formulation. J Pharm Investig. 2018;48:333–340.
  • Lachman L, Lieberman HA, Kanig JL. The theory and practice of industrial pharmacy. Philadelphia (PA): Lea Febiger. 1986.
  • Liu JY, Zhang XX, Huang HY, et al. Esomeprazole magnesium enteric-coated pellet-based tablets with high acid tolerance and good compressibility. J Pharm Investig. 2018;48:341–350.
  • Faqih AMN, Mehrotra A, Hammond SV, et al. Effect of moisture and magnesium stearate concentration on flow properties of cohesive granular materials. Int J Pharm. 2007;336:338–345.
  • Dürig T, Fassihi R. Mechanistic evaluation of binary effects of magnesium stearate and talc as dissolution retardants at 85% drug loading in an experimental extended‐release formulation. J Pharm Sci. 1997;86:1092–1098.
  • Roblegg E, Jäger E, Hodzic A, et al. Development of sustained-release lipophilic calcium stearate pellets via hot melt extrusion. Eur J Pharm Biopharm. 2011;79:635–645.
  • Javadzadeh Y, Adibkia K, Bozorgmehr Z, et al. Evaluating retardation and physicochemical properties of co-ground mixture of Na-diclofenac with magnesium stearate. Powder Technol. 2012;218:51–56.
  • Pather SI, Russell I, Syce JA, et al. Sustained release theophylline tablets by direct compression: Part 1: formulation and in vitro testing. Int J Pharm. 1998;164:1–10.
  • Roblegg E, Ulbing S, Zeissmann S, et al. Development of lipophilic calcium stearate pellets using ibuprofen as model drug. Eur J Pharm Biopharm. 2010;75:56–62.
  • Xu D, Wang X, Jiang J, et al. Impact of whey protein–Beet pectin conjugation on the physicochemical stability of β-carotene emulsions. Food Hydrocoll. 2012;28:258–266.
  • Niederquell A, Machado AH, Kuentz M. A diffusing wave spectroscopy study of pharmaceutical emulsions for physical stability assessment. Int J Pharm. 2017;530:213–223.
  • Pegel S, Pötschke P, Petzold G, et al. Dispersion, agglomeration, and network formation of multiwalled carbon nanotubes in polycarbonate melts. Polymer. 2008;49:974–984.
  • Kašpar O, Tokárová V, Oka S, et al. Combined UV/vis and micro-tomography investigation of acetaminophen dissolution from granules. Int J Pharm. 2013;458:272–281.
  • Maggi L, Bruni R, Conte U. High molecular weight polyethylene oxides (PEOs) as an alternative to HPMC in controlled release dosage forms. Int J Pharm. 1999;195:229–238.
  • Monteyne T, Adriaensens P, Brouckaert D, et al. Stearic acid and high molecular weight PEO as matrix for the highly water soluble metoprolol tartrate in continuous twin-screw melt granulation. Int J Pharm. 2016;512:158–167.
  • Dash S, Murthy PN, Nath L, et al. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm. 2010;67:217–223.
  • Anbalagan P, Liew CV, Heng P. Role of dwell on compact deformation during tableting: an overview. J Pharm Investig. 2017;47:173–181.
  • Vervaeck A, Saerens L, De Geest B, et al. Prilling of fatty acids as a continuous process for the development of controlled release multiparticulate dosage forms. Eur J Pharm Biopharm. 2013;85:587–596.
  • Yao N, Zhang P, Song L, et al. Stearic acid coating on circulating fluidized bed combustion fly ashes and its effect on the mechanical performance of polymer composites. Appl Surf Sci. 2013;279:109–115.
  • Desai D, Kothari S, Chen W, et al. Fatty acid and water‐soluble polymer‐based controlled release drug delivery system. J Pharm Sci. 2011;100:1900–1912.
  • Lee KH, Park C, Oh G, et al. New blends of hydroxypropylmethylcellulose and Gelucire 44/14: physical property and controlled release of drugs with different solubility. J Pharm Investig. 2018;48:313–321.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.